tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EDIT Stock Latest News

Editas Medicine Announces CFO Transition
Company AnnouncementsEditas Medicine Announces CFO Transition
14d ago
8K
EDIT
Dyne Therapeutics appoints Erick Lucera as CFO
PremiumThe Fly
Dyne Therapeutics appoints Erick Lucera as CFO
14d ago
DYN
EDIT
Editas Medicine CFO Erick Lucera to step down, Amy Parison to succeed
PremiumThe Fly
Editas Medicine CFO Erick Lucera to step down, Amy Parison to succeed
14d ago
EDIT
Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones
PremiumRatings
Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones
20d ago
EDIT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
28d ago
ACIU
ADMA
Sell Rating for Editas Medicine Amid Strategic Shift and Competitive Pressures
PremiumRatingsSell Rating for Editas Medicine Amid Strategic Shift and Competitive Pressures
28d ago
EDIT
Buy Rating for Editas Medicine Driven by Promising Preclinical Advances and Strong Financial Position
Premium
Ratings
Buy Rating for Editas Medicine Driven by Promising Preclinical Advances and Strong Financial Position
28d ago
EDIT
Editas Medicine: Hold Rating Maintained Amid Strategic Advancements and Financial Stability
Premium
Ratings
Editas Medicine: Hold Rating Maintained Amid Strategic Advancements and Financial Stability
28d ago
EDIT
Editas Medicine Inc.’s Stock Volatility: Key Risks and Investor Considerations
PremiumCompany Announcements
Editas Medicine Inc.’s Stock Volatility: Key Risks and Investor Considerations
28d ago
EDIT
Editas Medicine: Balancing Financial Stability and Strategic Uncertainties with a Hold Rating
PremiumRatings
Editas Medicine: Balancing Financial Stability and Strategic Uncertainties with a Hold Rating
29d ago
EDIT
Editas Medicine Reports Progress in Gene Editing
PremiumCompany Announcements
Editas Medicine Reports Progress in Gene Editing
29d ago
EDIT
Editas Medicine reports Q4 EPS (55c), consensus (33c)
PremiumThe Fly
Editas Medicine reports Q4 EPS (55c), consensus (33c)
29d ago
EDIT
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsEDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
EDIT
3 Penny Stocks to Watch Now, 2/20/25
Premium
Market News
3 Penny Stocks to Watch Now, 2/20/25
1M ago
EDIT
SINT
Bargain Basement CRISPR Therapeutics Becomes Takeover Target
Premium
Market News
Bargain Basement CRISPR Therapeutics Becomes Takeover Target
2M ago
CRSP
EDIT
Editas Medicine Outlines 2025 Strategic Priorities and Milestones
PremiumCompany Announcements
Editas Medicine Outlines 2025 Strategic Priorities and Milestones
3M ago
8K
EDIT
Editas Medicine announces strategic priorities, 2025 key milestones
PremiumThe Fly
Editas Medicine announces strategic priorities, 2025 key milestones
3M ago
EDIT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
VIR
BCYC
Editas Medicine price target lowered to $5 from $7 at Evercore ISI
PremiumThe Fly
Editas Medicine price target lowered to $5 from $7 at Evercore ISI
4M ago
EDIT
Editas Medicine downgraded to Underweight from Neutral at JPMorgan
PremiumThe FlyEditas Medicine downgraded to Underweight from Neutral at JPMorgan
4M ago
EDIT
Editas Medicine downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Editas Medicine downgraded to Hold from Buy at JonesResearch
4M ago
EDIT
Salesforce upgraded, ServiceNow downgraded: Wall Street’s top analyst calls
Premium
The Fly
Salesforce upgraded, ServiceNow downgraded: Wall Street’s top analyst calls
4M ago
ZI
ACI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >